Aurobindo Pharma Limited — Updates, 19-09-2025: General Updates

Aurobindo Pharma's subsidiary, APL Healthcare, faced a minor fire at its Unit-IV, affecting two production lines. This is expected to cause a temporary ~3% production impact to the unit's monthly capacity. Operations are anticipated to normalize within weeks, with no material financial or operational impact.